Lockheed Martin Corporation (“LMC”) has recently faced allegations by a whistleblower on behalf of the Department of Justice (“DOJ”) over defense contractor fraud under the False Claims Act (“FCA”). The company was accused of not disclosing its knowledge of cost or pricing data in its possession to the Joint Program Office (“JPO”). On February 6, 2025, the DOJ announced that LMC had reached a settlement of $29.74 million to resolve…
Reporting misconduct in the workplace is a courageous act that often comes with considerable stress and uncertainty. While whistleblowers play a crucial role in upholding integrity and accountability within organizations, fear of retaliation can make the decision to speak out particularly challenging. At Miller Shah, we recognize the pressures whistleblowers face. Our mission is to help these individuals understand their legal protections and provide the guidance they need to bring…
There are serious legal consequences to violating the False Claims Act (“FCA”), particularly in cases involving illegal kickbacks in the healthcare industry, as demonstrated by the $17 million Bard fraud settlement. This settlement resolved allegations that C.R. Bard, Inc. and its affiliates provided unlawful incentives to urology practice groups to influence medical device prescriptions. The lawsuit alleged that Bard and its subsidiaries improperly offered discounts, free samples, and cost-saving benefits…
The Dodd-Frank Wall Street Reform and Consumer Protection Act, enacted in 2010, is one of the most significant regulatory overhauls in the history of the United States since the Great Depression. It was introduced in response to the catastrophic financial crisis of 2008, aiming to bring greater stability and transparency to the financial industry. The law's provisions are designed to reduce risk, increase accountability, and provide robust consumer protections to…
The integrity of capital markets is paramount to supporting a fair and efficient financial landscape. Fraud and manipulation pose significant threats to the stability and fairness of these markets, potentially undermining investor confidence and economic growth. The U.S. Securities and Exchange Commission (SEC) is a pivotal institution in combating these issues, ensuring markets operate transparently and efficiently. The SEC's Mission The SEC was established in 1934 in response to the…
Blowing the whistle on fraud in the workplace can be a challenging decision, especially when considering the potential for retaliation and financial repercussions. However, the significant impact of the individuals who come forward and file qui tam lawsuits cannot be overstated. That is why Miller Shah LLP is committed to helping clients navigate the complex statutory schemes designed to protect whistleblowers and ensure accountability and integrity. What Is a Qui…
On July 30, 2024, Chief U.S. District Judge Mitchell S. Goldberg of the Eastern District of Pennsylvania denied a request to appeal his interpretation of the Centers for Medicare and Medicaid Services' regulations from CVS Caremark Corp. ("Defendant" or "Caremark" or the "Company") in a qui tam lawsuit against the Company for falsely reporting prescription drug prices to the government in violation of the False Claims Act ("FCA"), 31 U.S.C.…
The False Claims Act (FCA) is a legal measure designed to protect the integrity of government expenditures. Enacted during the American Civil War in 1863, its primary purpose was to curb defense contractor fraud, an objective that has since broadened to encompass a range of fraudulent activities against the federal government. At Miller Shah LLP, we continue that commitment to justice by supporting whistleblowers who bring fraudulent activities to light…
On July 21, 2023, the Department of Justice (“DOJ”) announced that Booz Allen Hamilton Holding Corporation (“Booz Allen” or the “Company”), a Virginia-based provider of data analytics, digital solutions, and consulting services, has agreed to pay $377.45 million to resolve alleged violations of the False Claims Act, 31 U.S.C. §§ 3729–3733 (“FCA”). The settlement, one of the biggest procurement fraud settlements in DOJ history, specifically resolves allegations that Booz Allen…
On August 18, 2022, a District Judge in the United States District Court for the Southern District of California granted in part and denied in part the motion to dismiss the False Claims Act lawsuit against Abbott Laboratories, Inc. a/k/a Abbott Laboratories, Abbott Cardiovascular Systems Inc., and Abbott Vascular Inc., (collectively, “Abbott” or the “Company”), sustaining the federal claims but dismissing the state claims in the action. The False Claims Act,…
PA Philadelphia | 866-540-5505
NY New York City | 866-540-5505
NJ Hoboken | 866-540-5505
CA San Diego | 866-540-5505
NY New York City | 866-540-5505
CT Chester | 866-540-5505
PA Philadelphia | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
CA San Francisco | 866-540-5505
NY New York City | 866-540-5505
FL Fort Lauderdale | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
CT Chester | 866-540-5505
NY New York City | 866-540-5505
CA Los Angeles | 866-540-5505
CA Los Angeles | 866-540-5505
CT Chester | 866-540-5505
FL Fort Lauderdale | 866-540-5505
CT Chester | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
PA Philadelphia | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
CA San Diego | 866-540-5505
PA Philadelphia | 866-540-5505
CT Chester | 866-540-5505
NY New York City | 866-540-5505
CA San Diego | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
FL Fort Lauderdale | 866-540-5505
NJ Hoboken | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
IT Milan | 866-540-5505
PA Philadelphia | 866-540-5505
CA San Francisco | 866-540-5505
CT Chester | 866-540-5505
NY New York City | 866-540-5505
CT Chester | 866-540-5505
PA Philadelphia | 866-540-5505
CA San Diego | 866-540-5505
PA Philadelphia | 866-540-5505
CA Los Angeles | 310-203-0600